Medical and nonmedical therapies for benign prostatic hypertrophy.
Benign prostatic hypertrophy (BPH) is a common disorder of elderly men, affecting about 80% of men by the age of 80. Until recently, therapeutic options were limited, and transurethral surgery was the most common remedy. In recent years, however, a number of alternatives to traditional surgery have evolved. This article reviews and evaluates current medical and nonmedical therapies for BPH.
Loughlin
K R
KR
Division of Urological Surgery, Brigham and Women's Hospital, Boston.
D000368:Aged; D000726:Androgen Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D002404:Catheterization / Q000523:psychology / Q000592:standards / Q000706:statistics & numerical data; D003258:Consumer Behavior; D004967:Estrogens / Q000494:pharmacology / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery*; D014521:Urethra / Q000601:surgery
D000726:Androgen Antagonists; D004967:Estrogens; D007987:Gonadotropin-Releasing Hormone